Item 1. Business
ITEM 1. BUSINESS
Introduction
A SPAC III Acquisition Corp.
(the “Company”) is a blank check company incorporated as a British Virgin Island (“BVI”) business company on September
3, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses (the “Business Combination”).
Initial Public Offering and Private Placement
On November 12, 2024, the
Company consummated its IPO of 5,500,000 units (“Units”). Each Unit consists of one Class A ordinary share (the “Class
A Ordinary Share”), no par value per share, and one right (the “Right”) to receive of one-tenth of one Class A ordinary
share upon the completion of the initial Business Combination. The Units were sold at an offering price of $10.00 per Unit, generating
total gross proceeds of $55,000,000.
Simultaneously with the consummation
of the IPO and the sale of the Units, the Company consummated the private placement (“Private Placement”) of 280,000 units
(the “Private Placement Units”) to A SPAC III (Holdings) Corp. (the “Sponsor”), at a price of $10.00 per Private
Placement Unit, generating total proceeds of $2,800,000. The Private Placement Units are identical to the Units sold in the IPO. Additionally,
the Sponsor and holders of our Founder Shares (the “initial shareholders”) agreed not to transfer, assign or sell any of the
Private Placement Units or underlying securities (except in limited circumstances, as described in the Registration Statement) until after
the completion of the Company’s initial business combination. Such initial shareholders were granted certain demand and piggyback
registration rights in connection with the purchase of the Private Placement Units. The Private Placement Units were issued pursuant to
Section 4(a)(2) of the Securities Act of 1933, as amended, as the transactions did not involve a public offering.
The Company granted the underwriters
a 45-day option to purchase up to 825,000 additional Units to cover over-allotments. Subsequently, on November 15, 2024, Maxim Group LLC,
the representative of the underwriter of the IPO (“Maxim”) notified the Company of their election to partially exercise the
over-allotment option and to purchase an additional 500,000 Units of the Company (the “Over-Allotment Option Units”). The
closing of the issuance and sale of the Over-Allotment Option Units occurred on November 19, 2024. The total aggregate issuance by the
Company of 500,000 Over-Allotment Option Units at the price of $10.00 per unit generated total gross proceeds of $5,000,000. On November
19, 2024, simultaneously with the closing and sale of the Over-Allotment Option Units, the Company consummated the private sale of an
additional 5,000 Private Placement Units to the Sponsor, generating gross proceeds of $50,000.
As a result of the underwriter’s
partial exercise of the over-allotment option on November 19, 2024, 81,250 shares of Class B ordinary share were forfeited for no consideration.
In connection with the IPO
and issuance and sales of the Over-Allotment Option Units, the Company issued to Maxim, an aggregate of 270,000 Class A ordinary shares
for no consideration (the “Representative Shares”).
A total of $60,000,000 of
the net proceeds from the IPO (including the Over-Allotment Option Units) and the Private Placement were deposited in a trust account
established for the benefit of the Company’s public shareholders (the “Trust Account”). None of the funds held in trust
will be released from the Trust Account, other than interest income to pay any tax obligations, until the earlier to occur of (i) the
completion of the initial Business Combination, (ii) the redemption of any public shares properly tendered in connection with a shareholder
vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of
the Company’s obligation to redeem 100% of the public shares if the Company does not complete the initial Business Combination within
the Combination Period (defined below) or (B) with respect to any other provision relating to shareholders’ rights or pre-Business
Combination activity and (iii) the redemption of all of the public shares if the Company is unable to complete the initial Business Combination
within the Combination Period, subject to applicable law and as further described in the Prospectus.
1
As of December 31, 2025, the
Company had not commenced any operations. All activities for the period from September 3, 2021 (inception) through December 31, 2025 were
organizational activities and those necessary to prepare for the Initial Public Offering (the “IPO”), and, following our IPO,
searching for a Business Combination target and the negotiation with potential targets for an initial Business Combination. The Company
will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company
will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO.
On January 1, 2025, the Company
announced that holders of the Company’s units may elect to separately trade the Class A ordinary shares and rights included in its
units commencing on or about January 3, 2025. The Class A Ordinary Shares and Rights are currently trading on the Nasdaq Capital Market
(“Nasdaq”) under the symbols “ASPC” and “ASPCR,” respectively. Public Units not separated will continue
to trade on Nasdaq under the symbol “ASPCU”. Holders of Public Units will need to have their brokers contact the Company’s
transfer agent, Continental Stock Transfer & Trust Company, in order to separate the holders’ Public Units into Class A Ordinary
Shares and Rights.
Business Agreements Subject to Definitive Agreements
On December 31, 2024, the
Company entered into an agreement with HDEducation Group Limited, a Cayman Islands exempted company (“HD Group”) (the “HD
Group Agreement”). HD Group is headquartered in Anji County, China, and is a comprehensive service platform for students pursuing
university education globally. The Agreement is intended to express a mutual indication of interest, and remains subject, in all respect,
to the execution of definitive agreements. Pursuant to the terms of the Agreement, the aggregate consideration to be paid to existing
shareholders of HD Group is $300,000,000, which will be paid entirely in stock, comprised of newly issued Class A ordinary shares and
Class B ordinary shares of A SPAC III Mini Acquisition Corp., a to-be-formed British Virgin Islands business company and the Company’s
its wholly owned subsidiary at a price of $10.00 per share. On May 21, 2025, the HD Group Agreement was terminated by mutual agreement
by the Company and HD Group.
On January 24, 2025, the Company entered into an agreement with Bioserica
International Limited 禾素國際有限公司, a British Virgin Islands business company (“Bioserica”)
(the “Bioserica Agreement”). Bioserica is in the business of researching and developing, manufacturing, marketing and sales
of bio-based antimicrobial materials. The Bioserica Agreement is intended to express a mutual indication of interest, reflects additional
terms negotiated, and remains subject, in all respect, to the execution of definitive agreements.
Merger Agreement
On May 23, 2025, the Company entered into a merger agreement (as it
may be amended, supplemented or otherwise modified from time to time, the “Merger Agreement”) with (i) Bioserica, (ii) A SPAC
III Mini Acquisition Corp., a British Virgin Islands business company and wholly-owned subsidiary of the Company (the “PubCo”),
and (iii) A SPAC III Mini Sub Acquisition Corp., a British Virgin Islands business company formed as a wholly owned subsidiary of PubCo
(“Merger Sub”).
Pursuant to the Merger Agreement, among other things, (i) the Company
will merge with and into PubCo, the separate corporate existence will cease and PubCo will continue as the surviving corporation (the
“Reincorporation Merger”), and (ii) the Merger Sub will merge with and into Bioserica and Bioserica will continue as the surviving
company under the laws of the British Virgin Islands and become a wholly owned subsidiary of PubCo (the “Acquisition Merger”).
Pursuant to the terms of the Merger Agreement, the aggregate consideration for the Acquisition Merger is $217,860,000, consisting of (i)
$200,000,000, payable in the form of 20,000,000 newly issued PubCo Class B ordinary shares, valued at $10.00 per share; and (ii) $17,860,000,
payable in the form of 1,786,000 newly issued PubCo Class A ordinary shares, valued at $10.00 per share (assuming that Bioserica would
receive an aggregate of $12,500,000 investment from third parties prior to Closing).
2
The Merger Agreement contains customary representations, warranties
and covenants of the parties thereto. The consummation of the transactions contemplated by the Merger Agreement is subject to certain
conditions as further described in the Merger Agreement.
The foregoing description
of the Merger Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions of the Merger Agreement,
a copy of which is filed as Exhibit 2.1 to the Current Report on Form 8-K filed on May 27, 2025, and incorporated by reference herein.
Concurrently with the execution
of the Merger Agreement, Bioserica, PubCo, the Company and a shareholder of Bioserica (the “Supporting Shareholder”) entered
into a voting and support agreement (“Voting and Support Agreement”) pursuant to which such the Supporting Shareholder has
agreed, among other things, to vote in favor of the Acquisition Merger, the adoption of the Merger Agreement and any other matters necessary
or reasonably requested by Bioserica, PubCo or the Company for consummation of the Acquisition Merger and the other transactions contemplated
by the Merger Agreement. In addition, the Supporting Shareholder has agreed not to sell, assign, encumber, pledge, hypothecate, dispose,
loan or otherwise transfer the shares of the Company owned of record and beneficially by such Supporting Shareholder or over which such
Supporting Shareholder has voting power, prior to the earlier to occur of (a) the closing of the Acquisition Merger, (b) the termination
of the Merger Agreement, and (c) written agreement of the Supporting Shareholder, on the one hand, and the Company and PubCo, on the other
hand.
Reorganization
On September 10, 2025, the
Company completed an internal reorganization, pursuant to which Merger Sub became a wholly owned subsidiary of the Company (the “Reorganization”).
As part of the Reorganization, PubCo transferred 100% of the issued and outstanding equity of Merger Sub to the Company.
Competitive Strengths
We will seek to capitalize
on the experience and networks of the members of our management and director team: Mr. Claudius Tsang, Mr. Pang Wai Yuen Marvin, Mr. Wong
Yi Dung Eden and Mr. Xiangge Liu. Our team consists of seasoned and experienced professionals who have significant experience in both
public and private companies. Members of our management also have experience in sourcing and evaluating potential investment targets as
well as deal negotiation, corporate finance, business operations and management. Our team has developed a proprietary network of relationships
with business leaders, investors and intermediaries that we believe can generate deal flow for us.
Mr. Claudius Tsang, our Chief
Executive Officer, Chief Financial Officer and Chairman, has over 20 years of experience in capital markets, with a strong track record
in private equity, M&A transactions and PIPE investments with a focus on Greater China and other emerging markets. Mr. Xiangge Liu,
our Independent Director, has over 25 years of extensive experience in private equity, project finance and advisory services. Mr. Wong
Yi Dung Eden, our Independent Director, is an experienced leader in the finance and investment management space, having founded and managed
multiple investment firms and serving in senior roles at various financial institutions. Mr. Pang Wai Yuen Marvin, our Independent Director,
has expertise in finance, investment management and business development, with significant roles in corporate finance and capital market
advisory activities.
We believe the experience
and network of relationships of our management and director team will give us advantages in sourcing, structuring and consummating a business
combination. However, none of our management and director team is obligated to remain with the company after an acquisition transaction,
and we cannot provide assurance that the resignation or retention of our current management will be a term or condition in any agreement
relating to an acquisition transaction. Moreover, despite the competitive advantages we believe we have, we remain subject to significant
competition with respect to identifying and executing an acquisition transaction.
Our management team’s
past performance is not an assurance that we will be able to identify an appropriate candidate for our initial business combination or
achieve success with respect to the business combination we intend to consummate.
3
Redemption rights for public shareholders upon consummation of our
initial business combination
We will provide our public
shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination
at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account as of two business days prior
to the consummation of our initial business combination, including interest (which interest shall be net of taxes payable), divided by
the number of then outstanding public shares, subject to the limitations described herein.
The amount in the trust account
is initially anticipated to be $10.00 per public share (subject to increase of up to an additional $0.20 per share in the event that our
Sponsor elects to extend the period of time to consummate a business combination by the full six months). There will be no redemption
rights upon the completion of our initial business combination with respect to our public rights or private placement rights. Maxim (and
its designees), our Sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed (and
their permitted transferees will agree) to waive their redemption rights with respect to their founder shares, Private Placement Shares
(underlying the Private Placement Units) and/or Representative’s Shares. However, if our initial shareholder or any of our officers,
directors or affiliates acquires public shares in or after the initial public offering, they will be entitled to receive liquidating distributions
with respect to such public shares if we fail to consummate our initial business combination within the required time period.
Redemption of public shares and liquidation if no initial business
combination
The Company initially had
12 months from the closing of the IPO (or up to 18 months if the Company extends the date by which it has to complete a business combination)
to consummate an initial business combination. Currently, as a result of the shareholders’ approval at the 2025 EGM (as defined
below), the Company amended and restated its memorandum and articles of association to extend the date by which it has to complete a business
combination (the “Combination Period”) to November 12, 2026, or up to 24 months from the IPO. If we are unable to consummate
our initial business combination within the time period specified in our amended and restated memorandum and articles of association,
we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten
business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit
in the Trust Account, including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution
expenses) divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’
rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of the Board of Directors, liquidate and dissolve,
subject in each case to the Company’s obligations under British Virgin Islands law to provide for claims of creditors and the requirements
of other applicable law.
Following the redemption of
public shares, we intend to enter “voluntary liquidation” which is the statutory process for formally closing and dissolving
a company under the laws of the British Virgin Islands. Given that we intend to enter voluntary liquidation following the redemption of
public shareholders from the trust account, we do not expect that the voluntary liquidation process will cause any delay to the payment
of redemption proceeds from our trust account. In connection with such a voluntary liquidation, the liquidator would give notice to creditors
inviting them to submit their claims for payment, by notifying known creditors (if any) who have not submitted claims and by placing a
public advertisement in at least one newspaper published in the British Virgin Islands newspaper and in at least one newspaper circulating
in the location where the company has its principal place of business, and taking any other steps he considers appropriate to identify
the company’s creditors, after which our remaining assets would be distributed. As soon as the affairs of the company are fully
wound-up, the liquidator must complete his statement of account and file notice with the Registrar that the liquidation is complete. We
would be dissolved once the Registrar issues a Certificate of Dissolution.
Our initial shareholder and
Maxim have agreed to waive their redemption rights with respect to their Founder Shares and Representative Shares if we fail to consummate
our initial business combination within the applicable period from the closing of our initial public offering.
4
However, if our initial shareholder,
or any of our officers, directors or affiliates acquire public shares in or after the initial public offering, they will be entitled to
redemption rights with respect to such public shares if we fail to consummate our initial business combination within the required time
period. There will be no redemption rights or liquidating distributions with respect to our Private Placement Units, which will expire
worthless in the event we do not consummate our initial business combination within the Combination Period. We will pay the costs of our
liquidation from our remaining assets outside of the trust account or interest earned on the funds held in the trust account. However,
the liquidator may determine that he or she requires additional time to evaluate creditors’ claims (particularly if there is uncertainty
over the validity or extent of the claims of any creditors). Also, a creditor or shareholder may file a petition with the BVI court which,
if successful, may result in our liquidation being subject to the supervision of that court. Such events might delay distribution of some
or all of our remaining assets.
Additionally, in any liquidation
proceedings of the company under British Virgin Islands law, the funds held in our trust account may be included in our estate and subject
to the claims of third parties with priority over the claims of our shareholders. To the extent any such claims deplete the trust account
we may not be able to return to our public shareholders the liquidation amounts payable to them.
If we do not complete an initial
business combination and expend all of the net proceeds of our initial public offering, other than the proceeds deposited in the trust
account, and without taking into account interest, if any, earned on the trust account or any amount that may be deposited into the trust
account to extend the date by which the Company has to complete a business combination, the per-share redemption amount received by shareholders
upon our dissolution would be approximately $10.00. The proceeds deposited in the trust account could, however, become subject to the
claims of our creditors, which would have higher priority than the claims of our public shareholders. The actual per-share redemption
amount received by shareholders may be less than $10.00, plus interest (net of taxes payable, and less up to $100,000 of interest to pay
liquidation expenses).
Although we will seek to have
all vendors, service providers, prospective target businesses or other entities with which we do business execute agreements with us waiving
any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public shareholders,
there is no guarantee that they will execute such agreements or even if they execute such agreements that they would be prevented from
bringing claims against the trust account including but not limited to fraudulent inducement, breach of fiduciary responsibility or other
similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with respect
to a claim against our assets, including the funds held in the trust account. If any third party refuses to execute an agreement waiving
such claims to the monies held in the trust account, our management will consider whether competitive alternatives are reasonably available
to us and will only enter into an agreement with a third party if management believes that such third party’s engagement would be
the best interests of the company under the circumstances. Examples of possible instances where we may engage a third party that refuses
to execute a waiver include the engagement of a third party consultant whose particular expertise or skills are believed by management
to be superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service
provider willing to execute a waiver. In addition, there is no guarantee that such entities will agree to waive any claims they may have
in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against
the trust account for any reason. In order to protect the amounts held in the trust account or any amount that may be deposited into the
trust account to extend the date by which the Company has to complete a business combination, our sponsor agreed that it will be liable
to us, if and to the extent any claims by a vendor for services rendered or products sold to us, or a prospective target business with
which we have discussed entering into a business combination agreement, reduce the amounts in the trust account to below $10.00 per share,
except as to any claims by a third party who executed a waiver of any and all rights to seek access to the trust account and except as
to any claims under our indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities
under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, our sponsor will not
be responsible to the extent of any liability for such third party claims. However, our sponsor may not be able to satisfy those obligations.
None of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective
target businesses. We have not independently verified whether our sponsor has sufficient funds to satisfy his indemnity obligations and
believe that our sponsor’s only assets are securities of our company.
5
In the event that the proceeds
in the trust account are reduced below $10.00 per share and our sponsor asserts that it is unable to satisfy any applicable obligations
or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take
legal action against our sponsor to enforce its indemnification obligations. It is possible that our independent directors in exercising
their business judgment may choose not to do so in any particular instance. Accordingly, due to claims of creditors, the actual value
of the per-share redemption price may be less than $10.00 per share.
We will seek to reduce the
possibility that our sponsor will have to indemnify the trust account due to claims of creditors by endeavoring to have all vendors, service
providers, prospective target businesses or other entities with which we do business execute agreements with us waive any right, title,
interest or claim of any kind in or to monies held in the trust account. Our sponsor will also not be liable as to any claims under our
indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act.
We will have access to funds not placed in the trust with which to pay any such potential claims. In the event that we liquidate and it
is subsequently determined that the reserve for claims and liabilities is insufficient, shareholders who received funds from our trust
account could be liable for claims made by creditors.
If we are deemed insolvent
for the purposes of the Insolvency Act, 2003 of the British Virgin Islands, as amended (the “Insolvency Act”) (i.e. (i) we
fail to comply with the requirements of a statutory demand that has not been set aside under section 157 of the Insolvency Act; (ii) execution
or other process issued on a judgment, decree or order of a British Virgin Islands Court in favor of a creditor of the company is returned
wholly or partly unsatisfied; or (iii) either the value of the company’s liabilities exceeds its assets, or the company is unable
to pay its debts as they fall due), then there are very limited circumstances where prior payments made to shareholders or other parties
may be deemed to be a “voidable transaction” for the purposes of the Insolvency Act. A voidable transaction would include,
for these purposes, payments made as “unfair preferences” or “transactions at an undervalue”. A liquidator appointed
over an insolvent company who considers that a particular transaction or payment is a voidable transaction under the Insolvency Act could
apply to the British Virgin Islands Courts for an order setting aside that payment or transaction in whole or in part.
Additionally, if we enter
insolvent liquidation under the Insolvency Act, the funds held in our trust account will likely be included in our estate and subject
to the claims of third parties with priority over the claims of our shareholders. To the extent any insolvency claims deplete the trust
account you may not be able to return to our public shareholders the liquidation amounts due them.
Our public shareholders will
be entitled to receive funds from the trust account only (i) in the event of a redemption of the public shares prior to any winding up
in the event we do not consummate our initial business combination within the Combination Period, (ii) if they redeem their shares in
connection with an initial business combination that we consummate or (iii) if they redeem their shares in connection with a shareholder
vote to amend our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation
to redeem 100% of our public shares if we do not complete our initial business combination within the time period specified in our amended
and restated memorandum and articles of association, or (B) with respect to any other provision relating to shareholders’ rights
or pre-business combination activity. In no other circumstances shall a shareholder have any right or interest of any kind to or in the
trust account. In the event we seek shareholder approval in connection with our initial business combination, a shareholder’s voting
in connection with the business combination alone will not result in a shareholder’s redeeming its shares to us for an applicable
pro rata share of the trust account. Such shareholder must have also exercised its redemption rights described above.
Acquisition Strategy
Our efforts in identifying
prospective target businesses will not be limited to a particular industry or country, although we intend to focus on businesses in the
Environmental, Sustainability and Governance (ESG) and material technology sector, an area where we believe has an optimistic growth trajectory
for the coming years. There is no restriction on the geographic location for our target search, and it is our intent to pursue targets
globally. Since our Sponsor and its affiliate(s) as well as certain of our current executive officers and directors are located or have
significant ties to China, we may acquire a target business that is based, from, expanded or has operations in China.
6
We will seek to capitalize
on the strength of our management team. We believe that our board and management’s experiences, from evaluating assets through investing,
company building and strategic management, will enable us to identify and execute an initial business combination with an attractive company
or businesses within the Environmental, Sustainability and Governance (ESG) and material technology market. We are not prohibited from
pursuing an initial business combination with a company that is affiliated with our Sponsor, officers or directors, or completing the
business combination through a joint venture or other form of shared ownership with our Sponsor, officers or directors. In the event we
seek to complete our initial business combination with a target that is affiliated with our Sponsor, officers or directors, or our Board
of Directors cannot independently determine the fair market value of the target business or businesses, we, or a committee of independent
directors, would obtain an opinion from an independent firm that commonly renders valuation opinions, independent accounting firm or independent
investment banking firm that our initial business combination is fair to our company from a financial point of view. We are not required
to obtain such an opinion in any other context.
Investment Criteria
Consistent with our acquisition
strategy, we have identified the following criteria to evaluate prospective target businesses. We will primarily seek to acquire one or
more growth businesses with a total enterprise value of between $100,000,000 and $600,000,000. Although we may decide to enter into our
initial business combination with a target business that does not meet any of the criteria described below, it is our intention to acquire
companies that we believe:
●
Has a competitive advantage. We intend to look for companies whose products and services are defensible and afford a differentiation solution to customers.
●
Has a strong management team that can create significant value for the target company. We are looking for proven management with a track record of executing and growing platforms who can credibly operate within public markets.
●
Is ready to be public, and will benefit from access to capital market. We will look for public-ready target companies that can leverage access to capital markets to fuel their growth and increase shareholder value.
These criteria are not intended
to be exhaustive. Any evaluation relating to the merits of a particular initial business combination may be based, to the extent relevant,
on these general guidelines as well as other considerations, factors and criteria that our management or board of directors may deem relevant.
We may decide to enter into our initial business combination with a target business that does not meet the above criteria and guidelines.
Initial Business Combination
NASDAQ rules require that
our initial business combination must be with one or more target businesses that together have an aggregate fair market value equal to
at least 80% of the balance in the trust account (less any taxes payable on interest earned and less any interest earned thereon that
is released to us for taxes) at the time of our signing a definitive agreement in connection with our initial business combination. If
our Board of Directors is not able to independently determine the fair market value of the target business or businesses, or we seek to
complete our initial business combination with a target that is affiliated with our Sponsor, officers or directors, we will obtain an
opinion from an independent investment banking firm or an independent accounting firm or any other firm that commonly renders valuation
opinions. We do not intend to purchase multiple businesses in unrelated industries in conjunction with our initial business combination.
We have until November 12,
2026 to consummate an initial business combination. If we are unable to consummate an initial business combination within such time period,
we will, as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding public shares,
at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including any interest earned
on the funds held in the Trust Account (net of interest that may be used by us to pay our taxes payable and less up to $100,000 of interest
to pay for dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish
public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject
to applicable law and as further described herein, and then seek to dissolve and liquidate. We expect the pro rata redemption price to
be approximately $10.00 per public share (regardless of whether or not the underwriters exercise their over-allotment option) (subject
to increase of up to an additional $0.20 per share in the event that our Sponsor elects to extend the period of time to consummate a business
combination by the full six months), without taking into account any interest earned on such funds. However, we cannot assure you that
we will in fact be able to distribute such amounts as a result of claims of creditors which may take priority over the claims of our public
shareholders.
7
We anticipate structuring
our initial business combination so that the post-transaction company in which our public shareholders own shares will own or acquire
100% of the equity interests or assets of the target business or businesses. We may, however, structure our initial business combination
such that the post-transaction company owns or acquires less than 100% of such interests or assets of the target business in order to
meet certain objectives of the target management team or shareholders or for other reasons, but we will only complete such business combination
if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires
a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company
Act of 1940, as amended, or the Investment Company Act. Even if the post-transaction company owns or acquires 50% or more of the voting
securities of the target, our shareholders prior to the business combination may collectively own a minority interest in the post-transaction
company, depending on valuations ascribed to the target and us in the business combination transaction. For example, we could pursue a
transaction in which we issue a substantial number of new shares in exchange for all of the outstanding capital stock of a target. In
this case, we would acquire a 100% controlling interest in the target. However, as a result of the issuance of a substantial number of
new shares, our shareholders immediately prior to our initial business combination could own less than a majority of our outstanding shares
subsequent to our initial business combination. If less than 100% of the equity interests or assets of a target business or businesses
are owned or acquired by the post-transaction company, the portion of such business or businesses that is owned or acquired is what will
be valued for purposes of the 80% of net assets test. If our initial business combination involves more than one target business, the
80% of net assets test will be based on the aggregate value of all of the target businesses.
Potential Legal and Operational Risks Associated with Acquiring
a Company that does Business in China
Although we currently do not
have any PRC subsidiary or China operations, certain of our executive officers and directors are located in, or have significant ties
to, China, which may make us a less attractive partner to potential target companies outside the PRC than a non-PRC related SPAC. On May
23, 2025, we entered the Merger Agreement with Bioserica, PubCo, and Merger Sub. Bioserica is not an operating company but a BVI holding
company with operations primarily conducted by its subsidiaries in China. If we consummate our initial business combination with Bioserica
or another target company that is a PRC company, the combined company may face various legal and operational risks and uncertainties after
the business combination, including, without limitation, regulatory review of overseas listing of PRC companies, restrictions on foreign
ownership in certain industries, regulatory changes in the variable interest entity (the “VIE”) structure, including the validity
and enforcement of the agreements in connection with such a VIE structure, if our target company is required to use such VIE structure.
We are also subject to the risks of uncertainty about any future actions of the PRC government in this regard, or if our PRC target company
fails to comply with their rules and regulations. Further, if the PRC target company uses a VIE structure, we will be subject to certain
legal and operational risks associated with VIE’s operations in the PRC. Specifically, if the Chinese regulatory authorities disallows
the VIE structure in the future, it will likely result in a material change in our financial performance and our results of operations
and/or the value of our securities post business combination with a PRC target, which could cause the value of our securities to significantly
decline or become worthless. PRC laws and regulations are sometimes vague and uncertain, and therefore, these risks may result in a material
change in our operations or the combined company’s principal operations in China, significant depreciation of the value of our or
the combined company’s securities, or a complete hindrance of our or the combined company’s ability to offer securities to
investors and cause the value of such securities to significantly decline or be worthless. The PRC government has significant authority
to exert influence on the ability of a China-based company to conduct its business, make or accept foreign investments or list on a U.S.
stock exchange. The PRC government has published policies that significantly affected certain industries such as the education and internet
industries, and we cannot rule out the possibility that it will in the future release regulations or policies regarding any industry that
could adversely affect us or our potential business combination with a PRC operating business and the business, financial condition, and
results of operations of the combined company. Further, due to (i) the risks associated with acquiring and operating a business in the
PRC and (ii) the fact that certain of our executive officers and directors are located in or have significant ties to China, it may make
a us a less attractive partner to certain potential target businesses, including non-China-based target companies and may also make it
more difficult for us to consummate a business combination with a China-based target business.
8
The PRC government also initiated
a series of regulatory actions and statements to regulate business operations in China, including adopting new measures to extend the
scope of cybersecurity reviews, and expanding the efforts in anti-monopoly enforcement. For example, according to the New Measures for
Cybersecurity Review (the “New Measures”) effective on February 15, 2022, network platform operators with personal information
of more than one million users must apply for cybersecurity review to the Cyber Security Review Office when they go public abroad, and
accordingly these companies may not be willing to list on a U.S. stock exchange or enter into a definitive business combination agreement
with us. We currently face risks associated with regulatory approvals of the proposed business combination between us and the target,
offshore offerings, anti-monopoly regulatory actions, and cybersecurity and data privacy. The PRC government may also intervene with or
influence our or the combined company’s operations as the government deems appropriate to further regulatory, political and societal
goals. Any such action, once taken by the PRC government, could result in a material change in our operations, including our search for
a target business, and make it more difficult and costly for us to consummate a business combination with a target business operating
in China, result in material changes in the combined company’s post-combination operations and cause the value of our securities
or those of the combined company’s securities to significantly decline, or in extreme cases, become worthless or completely hinder
our ability or the ability of the combined company to offer or continue to offer securities to investors.
If we consummate our initial
business combination with a PRC target company, we may operate in the PRC primarily through our PRC subsidiaries. We may also adopt a
series of contractual arrangements with the VIEs in the PRC, in which case (i) the VIEs will be PRC-based operations companies and our
PRC subsidiaries will be shell companies and (ii) investors in our securities will not and may never directly own equity interest in the
VIEs but will instead hold equity interest in a holding company of our PRC subsidiaries. Under the VIE arrangement, the dividends or other
distributions to be paid by our PRC subsidiaries to their overseas holding company will depend on such PRC subsidiaries’ entitlement
to substantially all of the economic benefits of the VIEs, which are typically in the form of services fees or license fees payable by
the VIEs to our PRC subsidiaries under various VIE agreements. Such contractual arrangements may not be as effective as direct ownership
in respect of our relationship with the VIE and we may be adversely affected if we experience difficulties in settling the amounts owed
to our PRC subsidiaries by the VIEs. All of these contractual arrangements may be governed by and interpreted in accordance with PRC law,
and disputes arising from these contractual arrangements may be resolved in court or through arbitration in China. However, the legal
environment in the PRC is not as developed as in some other jurisdictions. As a result, uncertainties in the PRC legal system could limit
our ability to enforce the contractual arrangements. There are very few precedents and little official guidance as to how contractual
arrangements should be interpreted or enforced under PRC law. The contractual arrangements have not been tested in a court of law in the
PRC and there remain significant uncertainties regarding the ultimate outcome of arbitration or court decisions should legal action become
necessary.
Currently, we are a single
entity and do not make any internal cash transfers. However, if our organizational structure expands, or if we acquire a PRC target company
which does not require a VIE structure, we may transfer funds to the PRC target company through an increase in the registered capital
of or a shareholder loan to the PRC target company. The PRC target company may in turn make distributions or pay dividends to us. If we
acquire a PRC target company which requires a VIE structure, the post-combination entity may rely on payments made from the VIE to a wholly
foreign-owned enterprise (the “WFOE”) and subsequently the WFOE distributes funds to the post-combination entity as dividends,
and cash to the PRC target company could be transferred through our organization in the manner as follows: (i) the holding company may
transfer funds to WFOE, via additional capital contributions or shareholder loans, as the case may be; and (ii) the WFOE may provide loans
to the PRC target company, subject to statutory limits and restrictions.
9
If we acquire a company based
in China, to the extent that the combined company in the future seeks to fund the business through distribution, dividends or transfer
of funds among and between holding company and subsidiaries, any such transfer of funds within and among the subsidiaries will be subject
to PRC regulations. Specifically, investment in Chinese companies is governed by the Foreign Investment Law, the dividends and distributions
from a PRC subsidiary are subject to regulations and restrictions on dividends and payment to parties outside of China, and any transfer
of funds among the PRC subsidiaries are allowed under and subject to regulations on private lending. Additionally, the PRC government
may impose controls on the conversion of Renminbi into foreign currencies and the remittance of currencies out of the PRC. In order for
the combined company to pay dividends to its shareholders, the combined company will rely on payments made from the PRC subsidiaries of
the combined company and the distribution of such payments to the combined company as dividends from the PRC subsidiaries of the combined
company. If we are to acquire a China-based operating company, the dividends and distributions from a PRC subsidiary are subject to regulations
and restrictions on dividends and payment to parties outside of China and the combined company may experience difficulties in completing
the administrative procedures necessary to obtain and remit foreign currency for the payment of dividends from its subsidiaries, if any.
Regardless of whether we have
a VIE structure or direct ownership structure post-business combination, we may depend on dividends and other distributions on equity
paid by our PRC subsidiaries for our cash and financing requirements. Due to (i) the risks of doing business in the PRC, and (ii) our
Sponsor and its affiliate(s) as well as certain of our current executive officers and directors are located in or have significant ties
to PRC, we may be a less attractive partner to non-PRC based target companies as compared to a non-PRC based special purpose acquisition
company (the “SPAC”) which may therefore make it harder for us to complete an initial business combination with a target company
that is non-PRC based and which may therefore make it more likely for us to consummate a business combination with a target company located
in the PRC.
Pursuant to the Holding Foreign
Companies Accountable Act, or the HFCAA, the PCAOB issued a Determination Report on December 16, 2021 which found that the PCAOB is unable
to inspect or investigate completely registered public accounting firms headquartered in (1) mainland China of the PRC because of a position
taken by one or more authorities in mainland China and (2) Hong Kong, a Special Administrative Region and dependency of the PRC, because
of a position taken by one or more authorities in Hong Kong. In addition, the PCAOB’s report identified the specific registered
public accounting firms which are subject to these determinations. On December 15, 2022, the PCAOB announced that PCAOB has secured complete
access to inspect and investigate public accounting firms headquartered in mainland China and Hong Kong, and vacated previous determinations
to the contrary. However, uncertainties exist with respect to the implementation of this framework and there is no assurance that the
PCAOB will be able to execute, in a timely manner, its future inspections and investigations in a manner that satisfies the Protocol.
Should PRC authorities obstruct or otherwise fail to facilitate the PCAOB’s access — in any way and at any point in the future
— the Board of PCAOB will act immediately to consider the need to issue a new determination. Our auditor, WWC, P.C. (“WWC”),
is a United States accounting firm based in California and registered with the PCAOB and is subject to regular inspection by the PCAOB.
WWC is not headquartered in mainland China or Hong Kong and was not identified in the Determination Report as a firm subject to the PCAOB’s
determinations. As a special purpose acquisition company, our current business activities only involve searching for targets and consummation
of a business combination.
In the event that we decide
to consummate our initial business combination with a target business based in or primarily operating in China, if there is any regulatory
change which prohibits the independent accountants from providing audit documentations located in mainland China or Hong Kong to the PCAOB
for inspection or investigation or the PCAOB expands the scope of the Determination Report so that the target company or the combined
company is subject to the HFCAA, as the same may be amended, you may be deprived of the benefits of such inspection which could result
in limitation or restriction to our access to the U.S capital markets and trading of our securities on a national securities exchange
or in the over-the-counter trading market in the U.S. may be prohibited, and our securities may be delisted by such exchange under the
HFCAA. On December 29, 2022, the President signed the Consolidated Appropriations Act, 2023, which, among other things, amended the HFCAA
to reduce the number of consecutive years an issuer can be identified as a Commission-Identified Issuer before the Commission must impose
an initial trading prohibition on the issuer’s securities from three years to two years. Therefore, once an issuer is identified
as a Commission-Identified Issuer for two consecutive years, the Commission is required under the HCFAA to prohibit the trading of the
issuer’s securities on a national securities exchange and in the over-the-counter market. If the combined company’s auditor
cannot be inspected by the PCAOB for two consecutive years, the trading of the securities on any U.S. national securities exchanges, as
well as any over-the-counter trading in the U.S., will be prohibited and the combined company’s securities may be delisted by such
exchange.
10
Furthermore, there may be
difficulties in effecting service of legal process, enforcing foreign judgments or bringing actions in China against us based on foreign
laws. Certain of our current executive officers and directors are located in, or have significant ties to, China. Also, if we decide to
consummate our initial business combination with a target business based in and primarily operating in China, it is possible that substantially
all or a significant portion of combined company’s assets may be located outside of the United States and some of the combined company’s
officers and directors may reside outside of the United States. As a result, it may be difficult to effect service of process upon these
officers and directors who reside outside of the United States. Even with effective service of process, it may also be difficult to enforce
in U.S. courts judgments obtained in U.S. courts based on the civil liability provisions of the U.S. federal securities laws against the
officers and directors. In addition, there is uncertainty as to whether the courts of the PRC would recognize or enforce judgments of
U.S. courts against the officers and directors predicated upon the civil liability provisions of the securities laws of the United States
or any state. The recognition and enforcement of foreign judgments are provided for under the PRC Civil Procedures Law. PRC courts may
recognize and enforce foreign judgments in accordance with the requirements of the PRC Civil Procedures Law based either on treaties between
China and the country where the judgment is made or on principles of reciprocity between jurisdictions. China does not have any treaties
or other forms of written arrangement with the United States that provide for the reciprocal recognition and enforcement of foreign judgments.
In addition, according to the PRC Civil Procedures Law, the PRC courts will not enforce a foreign judgment by us against the officers
or directors or the future combined company if they decide that the judgment violates the basic principles of PRC laws or national sovereignty,
security, or the public interest. As a result, it is uncertain whether and on what basis a PRC court would enforce a judgment rendered
by a court in the United States.
No PRC legal counsel had been
retained for purpose of the IPO and consequently the company did not rely on the advice of PRC counsel. The above discussion is based
on our management’s understanding of the current PRC laws, rules, regulations and local market practices and we cannot assure you
that our management’s understanding is correct. Furthermore, there would be added costs and issues with bringing an original action
in foreign courts against the combined company or the officers and directors to enforce liabilities based upon the U.S. Federal securities
laws, and they still may be fruitless. Uncertainties still exist as to how the rules and regulations could be interpreted or implemented
in the future, and the opinions stated above is subject to any new laws, rules and regulations or detailed implementations and interpretations.
Potential Approvals from the PRC Governmental Authorities for a
Business Combination
Our efforts in identifying
prospective target businesses will not be limited to a particular industry or country, although we intend to focus on businesses in ESG
and material technology sector. There is no restriction on the geographic location for our target search, and it is our intent to pursue
targets globally. Though we currently do not have any PRC subsidiary or China operations, we may consummate our initial business combination
with a target with principal operations in China and be subject to certain legal and operational risks associated with its operations
in the PRC. On May 23, 2025, we entered the Merger Agreement with Bioserica, PubCo, and Merger Sub. Bioserica is not an operating company
but a BVI holding company with operations primarily conducted by its subsidiaries in China.
The Regulations on Mergers
and Acquisitions of Domestic Companies by Foreign Investors (the “M&A Rules”), adopted by six PRC regulatory agencies
in 2006, and amended in 2009, require an offshore special purpose vehicle formed for the purpose of an overseas listing of securities
in a PRC company to obtain the approval of the CSRC prior to the listing and trading of such special purpose vehicle’s securities
on an overseas stock exchange. The scope of the M&A Rules covers two types of transactions: (a) equity deals where the acquisition
by a foreign investor, i.e., the offshore special purpose vehicle, of equity in a “PRC domestic company,” and (b) asset deals
where the acquisition by an offshore special purpose vehicle of the assets of a “PRC domestic company.” However, substantial
uncertainty remains regarding the scope and applicability of the M&A Rules to offshore special purpose vehicles and the above analysis
are subject to any new laws, rules and regulations or detailed implementation and interpretations in any form relating to the M&A
Rules.
On July 6, 2021, the General
Office of the Central Committee of the Communist Party of China and the General Office of the State Council jointly issued the Opinions
on Strictly Cracking Down on Illegal Securities Activities According to Law (the “Opinions”), which call for strengthened
regulation over illegal securities activities and supervision on overseas listings by China-based companies and propose to take effective
measures, such as promoting the development of relevant regulatory systems to deal with the risks and incidents faced by China-based overseas-listed
companies. The Opinions also provide that the State Council will revise provisions regarding the overseas issuance and listing of shares
by companies limited by shares and will clarify the duties of domestic regulatory authorities.
11
On February 17, 2023, the
CSRC promulgated the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies (the “Trial
Measures”), which took effect on March 31, 2023. The Trial Measures supersede the prior M&A Rules and clarified and emphasized
several aspects related to securities offerings, which include but are not limited to: (1) comprehensive determination of the “indirect
overseas offering and listing by PRC domestic companies” in compliance with the principle of “substance over form” and
particularly, an issuer will be required to go through the filing procedures under the Trial Measures if the following criteria are met
at the same time: (a) 50% or more of the issuer’s operating revenue, total profit, total assets or net assets as documented in its
audited consolidated financial statements for the most recent accounting year comes from PRC domestic companies, and (b) the main parts
of the issuer’s business activities are conducted in mainland China, or its main places of business are located in mainland China,
or the senior managers in charge of its business operation and management are mostly Chinese citizens or domiciled in mainland China;
(2) exemptions from immediate filing requirements for issuers that (a) have already been listed or registered but not yet listed in foreign
securities markets, including U.S. markets, prior to the effective date of the Trial Measures, (b) are not required to re-perform the
regulatory procedures with the relevant overseas regulatory authority or the overseas stock exchange, and (c) whose such overseas securities
offering or listing shall be completed before September 30, 2023, provided however that such issuers are required to carry out certain
filing procedures if they conduct refinancing or are involved in other circumstances that require filing with the CSRC; (3) a negative
list of types of issuers banned from listing or offering overseas, such as (a) issuers whose listing or offering overseas has been recognized
by the State Council of the PRC as a possible threat to national security, (b) issuers whose affiliates have been recently convicted of
bribery and corruption, (c) issuers under ongoing criminal investigations, and (d) issuers under major disputes regarding equity ownership;
(4) issuers’ compliance with web security, data security, and other national security laws and regulations; (5) issuers’ filing
and reporting obligations, such as the obligation to file with the CSRC after it submits an application for initial public offering to
overseas regulators, and the obligation after offering or listing overseas to report to the CSRC material events including a change of
control or voluntary or forced delisting of the issuer; and (6) the CSRC’s authority to fine both issuers and their shareholders
between 1 and 10 million RMB for failure to comply with the Trial Measures, including failure to comply with filing obligations or committing
fraud and misrepresentation.
Furthermore, pursuant to the
PRC Cybersecurity Law, which was promulgated by the Standing Committee of the National People’s Congress on November 7, 2016 and
took effect on June 1, 2017, personal information and important data collected and generated by a critical information infrastructure
operator in the course of its operations in China must be stored in China, and if a critical information infrastructure operator purchases
internet products and services that affects or may affect national security, it should be subject to cybersecurity review by the Cyberspace
Administration of China (“CAC”). In April 2020, the CAC and certain other PRC regulatory authorities promulgated the Measures
for Cybersecurity Review, which requires that operators of critical information infrastructure must pass a cybersecurity review when purchasing
network products and services which do or may affect national security. On January 4, 2022, the CAC, in conjunction with 12 other government
departments issued the New Measures for Cybersecurity Review (the “New Measures”). The New Measures amends the Measures for
Cybersecurity Review (Draft Revision for Comments) (the “Draft Measures”) released on July 10, 2021 and came into effect on
February 15, 2022. The New Measures include data processing activities of network platform operators that affect or may affect national
security into cybersecurity review and clarify that network platform operators with personal information of more than one million users
must apply for cybersecurity review to the Cybersecurity Review Office when they go public abroad. The PRC Data Security Law, which took
effect on September 1, 2021, imposes data security and privacy obligations on entities and individuals that carry out data activities,
provides for a national security review procedure for data activities that may affect national security and imposes export restrictions
on certain data and information. On August 20, 2021, the Standing Committee of the People’s Congress promulgated the PRC Personal
Information Protection Law (the “PIPL”), which is to take effect on November 1, 2021. The PIPL sets out the regulatory framework
for the handling and protection of personal information and the transmission of personal information overseas. If our potential future
target business in China involves collecting and retaining internal or customer data, it is our management’s understanding that
such target business might be subject to the relevant cybersecurity laws and regulations, including the PRC Cybersecurity Law and the
PIPL as discussed above, and that such target business needs to go through the cybersecurity review process before effecting a business
combination if it is deemed as a critical information infrastructure operator purchasing internet products and services that affects or
may affect national security, a network platform operator that affect or may affect national security, or a network platform operator
with personal information of more than one million users, we could be subject to PRC cybersecurity review.
12
No PRC legal counsel has been
retained by the Company. The above discussion is based on our management’s understanding of the current PRC laws, rules, regulations
and local market practices and we cannot assure you that our management’s understanding is correct. Uncertainties still exist as
to how rules and regulations could be interpreted or implemented in the future, and the opinions stated above is subject to any new laws,
rules and regulations or detailed implementations and interpretations.
Transfer of Cash to and from Our Post-Combination
Organization If We Acquire a Company Based in China (Post-Business Combination)
We are a blank check company
with no subsidiaries and no operations of our own except searching for a suitable target to consummate an initial business combination.
As of the date of this annual report, no transfers, dividends, or distribution have been made by us.
On May 23, 2025, we entered
the Merger Agreement with Bioserica, PubCo, and Merger Sub. Bioserica is not an operating company but a BVI holding company with operations
primarily conducted by its subsidiaries in China. If we decide to consummate our initial business combination with Bioserica or another
target business based in and primarily operating in China, the combined company whose securities will be listed on a U.S. stock exchange
may make capital contributions or extend loans to its PRC subsidiaries through intermediate holding companies subject to compliance with
relevant PRC foreign exchange control regulations. After the business combination, the combined company’s ability to pay dividends,
if any, to the shareholders and to service any debt it may incur will depend upon dividends paid by its PRC subsidiaries. Under PRC laws
and regulations, PRC companies are subject to certain restrictions with respect to paying dividends or otherwise transferring any of their
net assets to offshore entities. In particular, under the current PRC laws and regulations, dividends may be paid only out of distributable
profits. Distributable profits are the net profit as determined under Chinese accounting standards and regulations, less any recovery
of accumulated losses and appropriations to statutory and other reserves required to be made. A PRC company is required to set aside at
least 10% of its after-tax profits each year to fund certain statutory reserve funds (up to an aggregate amount equal to half of its registered
capital). As a result, the combined company’s PRC subsidiaries may not have sufficient distributable profits to pay dividends to
the combined company. Furthermore, if certain procedural requirements are satisfied, the payment in foreign currencies on current account
items, including profit distributions and trade and service related foreign exchange transactions, can be made without prior approval
from State Administration of Foreign Exchange (the “SAFE”) or its local branches. However, where Renminbi is to be converted
into foreign currency and remitted out of China to pay capital expenses, such as the repayment of loans denominated in foreign currencies,
approval from or registration with competent government authorities or its authorized banks is required.
The PRC government may take
measures at its discretion from time to time to restrict access to foreign currencies for current account or capital account transactions.
If the foreign exchange control regulations prevent the PRC subsidiaries of the combined company from obtaining sufficient foreign currencies
to satisfy their foreign currency demands, the PRC subsidiaries of the combined company may not be able to pay dividends or repay loans
in foreign currencies to their offshore intermediary holding companies and ultimately to the combined company. We cannot assure you that
new regulations or policies will not be promulgated in the future, which may further restrict the remittance of Renminbi into or out of
the PRC. We cannot assure you, in light of the restrictions in place, or any amendment to be made from time to time, that the PRC subsidiaries
of the combined company will be able to satisfy their respective payment obligations that are denominated in foreign currencies, including
the distribution of earnings from our businesses, including subsidiaries, to the parent company and U.S. investors as well as the ability
to settle amounts owed under contractual agreements.
13
Furthermore, the transfer
of funds among the PRC subsidiaries are subject to the Provisions of the Supreme People’s Court on Several Issues Concerning the
Application of Law in the Trial of Private Lending Cases (2020 Revision, the “Provisions on Private Lending Cases”), which
was issued by the Supreme People’s Court of the People’s Republic of China on August 25, 2015 and amended on August 19, 2020
and December 29, 2020, respectively, to regulate the financing activities between natural persons, legal persons and unincorporated organizations.
The Provisions on Private Lending Cases do not apply to the disputes arising from relevant financial services such as loan disbursement
by financial institutions and their branches established upon approval by the financial regulatory authorities to engage in lending business.
The Provisions on Private Lending Cases set forth that private lending contracts will be deemed invalid under the circumstance that (i)
the lender swindles loans from financial institutions for relending; (ii) the lender relends the funds obtained by means of a loan from
another profit-making legal person, raising funds from its employees, or illegally taking deposits from the public; (iii) the lender who
has not obtained the lending qualification according to the law lends money to any unspecified object of the society for the purpose of
making profits; (iv) the lender lends funds to a borrower when the lender knows or should have known that the borrower intended to use
the borrowed funds for illegal or criminal purposes; (v) the lending is violations of public orders or good morals; or (vi) the lending
violates mandatory provisions of laws or administrative regulations. The Provisions on Private Lending Cases set forth that the People’s
Court shall support the interest rates not exceeding four times of the market interest rate quoted for one-year loan at the time the private
lending contracts were entered into.
Enforceability of Civil Liabilities
We are incorporated under
the laws of the British Virgin Islands a business company with limited liability. The British Virgin Islands has a less developed body
of securities laws than the United States and provides less protection for investors. In addition, British Virgin Islands companies may
not have standing to sue before the federal courts of the United States.
As a result, it may be difficult,
or in some cases not possible, for investors in the United States to enforce their legal rights, to effect service of process upon those
officers and directors , to enforce judgments of United States courts predicated upon civil liabilities and criminal penalties on them
under United States securities laws.
Our directors and officers
are nationals or residents of jurisdictions other than the United States and all or a substantial portion of their assets are located
outside the United States. Further, there is uncertainty if any officers and directors of the post-combination entity will be located
outside the Unites States. As a result, it may be difficult, or in some cases not possible, for investors to enforce their legal rights,
to effect service of process upon those officers and directors (prior to or after the business combination) located outside the United
States to enforce judgments of United States courts predicated upon civil liabilities and criminal penalties on them under United States
securities laws or any state in the United States.
Furthermore, the PRC does
not have treaties providing for the reciprocal recognition and enforcement of judgments of courts with the United States and many other
countries and regions, and you may have to incur substantial costs and contribute significant time to enforce civil liabilities and criminal
penalties in reliance on legal remedies under PRC laws. Therefore, recognition and enforcement in the PRC of judgement of United States
courts in relation to any matter not subject to a binding arbitration provision may be difficult or impossible.
Extensions and Redemptions
On October 27, 2025, at its Extraordinary General
Meeting (the “2025 EGM”), the Company’s shareholders approved a proposal to amend and restate the Company’s amended
and restated memorandum and articles of association (the “Charter “) to, among other things, allow the Company to extend the
date by which it has to complete a business combination for an additional 12 months from November 12, 2025 to November 12, 2026. In connection
with the shareholders’ vote at the 2025 EGM, 5,717,419 Class A ordinary shares were tendered for redemption. On October 27, 2025,
following the shareholder approval, the Company filed the amended and restated memorandum and articles of Association (the “Amended
Charter”) with the British Virgin Islands Registrar of Corporate Affairs, giving the Company up to 24 months from its initial public
offering (i.e., until November 12, 2026) to consummate an initial business combination.
14
U.S. Foreign Investment Regulations
Mr. Claudius Tsang, our Chief
Executive Officer, Chief Financial Officer and Chairman, is the sole director of the Sponsor and as such is deemed to have sole voting
and investment discretion with respect to our shares held by the Sponsor. Mr. Tsang is not a U.S. person, and as of the date hereof, the
Sponsor owns approximately 76.4% of our issued and outstanding shares. Controlling or non-controlling investments in U.S. businesses that
produce, design, test, manufacture, fabricate or develop one or more critical technologies in one of 27 identified industries —
including aviation, defense, semiconductors, telecommunications and biotechnology — are subject to a mandatory filing with the Committee
on Foreign Investment in the U.S. (“CFIUS”). In addition, CFIUS is an interagency committee authorized to review certain transactions
involving foreign investment in the United States by foreign persons in order to determine the effect of such transactions on the national
security of the United States. Because we may be considered a “foreign person” under such rules and regulations, any proposed
business combination between us and a U.S. business engaged in a regulated industry or which may affect national security, we could be
subject to such foreign ownership restrictions and/or CFIUS review. The scope of CFIUS was expanded by the Foreign Investment Risk Review
Modernization Act of 2018 (“FIRRMA”) to include certain non-passive, non-controlling investments in sensitive U.S. businesses
and certain acquisitions of real estate even with no underlying U.S. business. FIRRMA, and subsequent implementing regulations that are
now in force, also subject certain categories of investments to mandatory filings. If our potential initial Business Combination with
a U.S. business falls within the scope of foreign ownership restrictions, we may be unable to consummate a business combination with such
business. In addition, if our potential business combination falls within CFIUS’s jurisdiction, we may be required to make a mandatory
filing or determine to submit a voluntary notice to CFIUS, or to proceed with the initial business combination without notifying CFIUS
and risk CFIUS intervention, before or after closing the initial business combination. CFIUS may decide to block or delay our initial
business combination, impose conditions to mitigate national security concerns with respect to such initial business combination or order
us to divest all or a portion of a U.S. business of the combined company if we had proceeded without first obtaining CFIUS clearance.
The foreign ownership limitations, and the potential impact of CFIUS, may limit the attractiveness of a transaction with us or prevent
us from pursuing certain initial business combination opportunities that we believe would otherwise be beneficial to us and our shareholders.
As a result, the pool of potential targets with which we could complete an initial business combination may be limited and we may be adversely
affected in terms of competing with other special purpose acquisition companies which do not have similar foreign ownership issues. Moreover,
the process of government review, whether by CFIUS or otherwise, could be lengthy. Because we have only a limited time to complete our
initial business combination our failure to obtain any required approvals within the requisite time period may require us to liquidate.
If we liquidate, our public shareholders may only receive $10.00 per share initially, and our rights will expire worthless. This will
also cause you to lose any potential investment opportunity in a target company and the chance of realizing future gains on your investment
through any price appreciation in the combined company.
Facilities
We currently maintain our
executive offices at The Sun’s Group Center, 29th Floor, 200 Gloucester Road, Wan Chai, Hong Kong. We consider our current office
space adequate for our current operations.
Competition
In identifying, evaluating
and selecting an alternate target business, we may encounter intense competition from other entities having a business objective similar
to ours. Many of these entities are well established and have extensive experience identifying and effecting business combinations directly
or through affiliates. Many of these competitors possess greater technical, human and other resources than us and our financial resources
will be relatively limited when contrasted with those of many of these competitors. While we believe there may be numerous potential target
businesses that we could acquire, our ability to compete in acquiring certain sizable target businesses may be limited by our available
financial resources.
The following also may not be viewed favorably
by certain target businesses:
● our
obligation to seek shareholder approval of a business combination or obtain the necessary financial information to be sent to shareholders
in connection with such business combination may delay or prevent the completion of a transaction;
● the
fact that there are fewer than ten months left in the Combination Period;
● Nasdaq
may require us to file a new listing application and meet its initial listing requirements to maintain the listing of our securities
following a business combination;
● our
outstanding Rights and unit purchase options and the potential future dilution they represent;
15
● our
obligation to register the resale of the Founder Shares, as well as the private units (and underlying securities) and any securities
issued to our initial shareholders, officers, directors or their affiliates upon conversion of working capital loans (if any); and
● the
impact on the target business’ assets as a result of unknown liabilities under the securities laws or otherwise depending on developments
involving us prior to the consummation of a business combination.
Any of these factors may place
us at a competitive disadvantage in successfully negotiating a business combination. If we succeed in effecting a business combination,
there will be, in all likelihood, intense competition from competitors of the target business. We cannot assure you that, subsequent to
a business combination, we will have the resources or ability to compete effectively.
Conflicts of Interest
Each of our sponsors, officers
and directors presently has, and in the future any of our directors and our officers may have additional, fiduciary or contractual obligations
to other entities pursuant to which such officer or director is or will be required to present acquisition opportunities to such entity.
Accordingly, subject to his or her fiduciary duties under British Virgin Islands law, if any of our officers or directors becomes aware
of an acquisition opportunity which is suitable for an entity to which he or she has then current fiduciary or contractual obligations,
he or she will need to honor his or her fiduciary or contractual obligations to present such acquisition opportunity to such entity, and
only present it to us if such entity rejects the opportunity. Our amended and restated memorandum and articles of association provide
that, subject to his or her fiduciary duties under British Virgin Islands law, we renounce our interest in any corporate opportunity offered
to any officer or director unless such opportunity is expressly offered to such person solely in his or her capacity as a director or
officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable
for us to pursue. However, we do not believe that any such potential conflicts would materially affect our ability to complete our initial
business combination, because our management team has experience in identifying and executing multiple acquisition opportunities simultaneously.
Emerging Growth Company Status and Other Information
We are an emerging growth
company as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (which we refer to herein as the JOBS Act). As such, we are eligible to take advantage of certain exemptions
from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but
not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002,
or the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements,
and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any
golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less
active trading market for our securities and the prices of our securities may be more volatile.
Further, Section 102(b)(1)
of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS
Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition
period which means that when a standard is issued or revised, and it has different application dates for public or private companies,
the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised
standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging
growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because
of the potential differences in accounting standards used.
16
We will remain an emerging growth company until the earlier
of (1) the last day of the fiscal year (a) following the fifth anniversary of the date of the IPO, (b) in which we have total annual
gross revenue of at least $1.235 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value
of our shares of common stock that are held by non-affiliates exceeds $700 million as of the prior June 30, and (2) the date on which
we have issued more than $1.0 billion in non-convertible debt during the prior three year period.
Additionally, we are a “smaller
reporting company” as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced
disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller
reporting company until the last day of the fiscal year in which (1) the market value of our ordinary shares held by non-affiliates exceeds
$250 million as of the end of that year’s second fiscal quarter, or (2) our annual revenues exceeded $100 million during such completed
fiscal year and the market value of our ordinary shares held by non-affiliates exceeds $700 million as of the end of that year’s
second fiscal quarter.
Employees
We currently have one officer.
This individual is not obligated to devote any specific number of hours to our matters and intend to devote only as much time as they
deem necessary to our affairs. The amount of time they will devote in any time period will vary based on whether a target business has
been selected for the business combination and the stage of the business combination process the company is in. We do not intend to have
any full time employees prior to the consummation of a business combination.
ITEM 1A. RISK FACTORS
As a smaller reporting company,
we are not required to include risk factors in this Annual Report.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.